Literature DB >> 21285466

A review of acute cyanide poisoning with a treatment update.

Jillian Hamel1.   

Abstract

Cyanide causes intracellular hypoxia by reversibly binding to mitochondrial cytochrome oxidase a(3). Signs and symptoms of cyanide poisoning usually occur less than 1 minute after inhalation and within a few minutes after ingestion. Early manifestations include anxiety, headache, giddiness, inability to focus the eyes, and mydriasis. As hypoxia progresses, progressively lower levels of consciousness, seizures, and coma can occur. Skin may look normal or slightly ashen, and arterial oxygen saturation may be normal. Early respiratory signs include transient rapid and deep respirations. As poisoning progresses, hemodynamic status may become unstable. The key treatment is early administration of 1 of the 2 antidotes currently available in the United States: the well-known cyanide antidote kit and hydroxocobalamin. Hydroxocobalamin detoxifies cyanide by binding with it to form the renally excreted, non-toxic cyanocobalamin. Because it binds with cyanide without forming methemoglobin, hydroxocobalamin can be used to treat patients without compromising the oxygen-carrying capacity of hemoglobin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21285466     DOI: 10.4037/ccn2011799

Source DB:  PubMed          Journal:  Crit Care Nurse        ISSN: 0279-5442            Impact factor:   1.708


  27 in total

1.  Hemodialysis failure secondary to hydroxocobalamin exposure.

Authors:  Kenneth Lim; Eliot Heher; David Steele; Andrew Z Fenves; John Kevin Tucker; Ravi Thadhani; Kenneth Christopher; Nina Tolkoff-Rubin
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-04

Review 2.  Neuroterrorism Preparedness for the Neurohospitalist.

Authors:  Maj Samuel A Ralston; Maj Brian P Murray; Daniel Vela-Duarte; Karen D Orjuela; Daniel M Pastula
Journal:  Neurohospitalist       Date:  2018-10-21

3.  Differential response to acrylonitrile toxicity in rat primary astrocytes and microglia.

Authors:  Samuel Caito; Yingchun Yu; Michael Aschner
Journal:  Neurotoxicology       Date:  2013-04-26       Impact factor: 4.294

4.  Multiparameter behavioral analyses provide insights to mechanisms of cyanide resistance in Caenorhabditis elegans.

Authors:  Jenifer N Saldanha; Archana Parashar; Santosh Pandey; Jo Anne Powell-Coffman
Journal:  Toxicol Sci       Date:  2013-06-26       Impact factor: 4.849

5.  Cytochrome P450 CYP71AT96 catalyses the final step of herbivore-induced phenylacetonitrile biosynthesis in the giant knotweed, Fallopia sachalinensis.

Authors:  Takuya Yamaguchi; Koji Noge; Yasuhisa Asano
Journal:  Plant Mol Biol       Date:  2016-02-29       Impact factor: 4.076

6.  Expression of the cyanobacterial enzyme cyanase increases cyanate metabolism and cyanate tolerance in Arabidopsis.

Authors:  Rashad Kebeish; Omar Al-Zoubi
Journal:  Environ Sci Pollut Res Int       Date:  2017-03-25       Impact factor: 4.223

7.  Protection from cyanide-induced brain injury by the Nrf2 transcriptional activator carnosic acid.

Authors:  Dongxian Zhang; Brian Lee; Anthony Nutter; Paul Song; Nima Dolatabadi; James Parker; Sara Sanz-Blasco; Traci Newmeyer; Rajesh Ambasudhan; Scott R McKercher; Eliezer Masliah; Stuart A Lipton
Journal:  J Neurochem       Date:  2015-03-11       Impact factor: 5.372

8.  Biosynthetic pathway for the cyanide-free production of phenylacetonitrile in Escherichia coli by utilizing plant cytochrome P450 79A2 and bacterial aldoxime dehydratase.

Authors:  Yuta Miki; Yasuhisa Asano
Journal:  Appl Environ Microbiol       Date:  2014-08-29       Impact factor: 4.792

9.  Report on a study of fires with smoke gas development : determination of blood cyanide levels, clinical signs and laboratory values in victims.

Authors:  G Geldner; E M Koch; U Gottwald-Hostalek; F Baud; G Burillo; J-P Fauville; F Levi; C Locatelli; T Zilker
Journal:  Anaesthesist       Date:  2013-08-07       Impact factor: 1.041

10.  Pallidal neuronal apolipoprotein E in pantothenate kinase-associated neurodegeneration recapitulates ischemic injury to the globus pallidus.

Authors:  Randall L Woltjer; Lindsay C Reese; Brian E Richardson; Huong Tran; Sarah Green; Thao Pham; Megan Chalupsky; Isabella Gabriel; Tyler Light; Lynn Sanford; Suh Young Jeong; Jeffrey Hamada; Leila K Schwanemann; Caleb Rogers; Allison Gregory; Penelope Hogarth; Susan J Hayflick
Journal:  Mol Genet Metab       Date:  2015-10-31       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.